Express Scripts — Merger or Acquisition (August 2018)
13 slides from Express Scripts's merger presentation, Aug 9, 2018
Slide 1: Cigna Reiterates Support for Proposed Merger with Express Scripts
CIGNA REITERATES SUPPORT FOR PROPOSED MERGER WITH EXPRESS SCRIPTS August 2018 Exhibit 99.1
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS Information included or incorporated by reference in this communication, and information which may be contained in other filings with the Securities and Exchange Commission (the “SEC”) and press releases or other public statements, contains or may contain forward-looking s
Slide 3: Important Information About the Transaction and Where to Find It
IMPORTANT INFORMATION ABOUT THE TRANSACTION AND WHERE TO FIND IT This communication does not constitute an offer to sell or solicitation of an offer to buy any securities. In connection with the proposed transaction, the newly formed company which will become the holding company following the transa
Slide 4: Cigna Strongly Disagrees With Mr. Icahn
Cigna Strongly Disagrees With Mr. Icahn – His Objection to the Express Scripts Merger is Not in the Best Interest of Cigna Shareholders As of close of business on August 6, 2018, Mr. Icahn holds only 0.56% of Cigna shares outstanding and has a “substantial” short position in Express Scripts Mr. Icah
Slide 5: Mr. Icahn's Assertions are Value Destructive and Misguided
Mr. Icahn’s Assertions are Value Destructive and Misguided A Mr. Icahn asserts that Cigna is overpaying for a highly challenged Express Scripts that is facing existential risks B C Mr. Icahn asserts that the problem of prescription drug pricing in America must be addressed by eliminating conflicting
Slide 6: Mr. Icahn demonstrates a lack of understanding of Cigna's business model
Mr. Icahn demonstrates a lack of understanding of Cigna's business model and how Cigna wins in the marketplace The integrated medical, pharmacy and behavioral services model has been the cornerstone of Cigna’s long-term strategy Cigna will not be able to inoculate itself from changes in the dynamic
Slide 7: Expanding Cigna's Capabilities and Distribution Reach by Acquiring Express Scripts
Expanding Cigna’s Capabilities and Distribution Reach by Acquiring Express Scripts is Strategically and Financially Attractive A The combined company will be well-positioned to adapt to changing competitive landscape “David Cordani CI CEO has built more management credibility in our view with the st
Slide 8: PBMs Provide Economic Value Beyond Rebates
PBMs Provide Economic Value Beyond Rebates, and Current Rebate Concerns are Known and Manageable B Potential changes to rebate regulation are not new Potential changes to Anti-Kickback statute safe harbor rules pertain to government programs and have been suggested in various forms Additionally, cha
Slide 9: PBMs Provide Economic Value Beyond Rebates: CMS Policy
“Curbing rebates is seemingly at odds with the administration’s push on Tuesday to expand them through price negotiation.” – Anna Edney (8/7/18) PBMs Provide Economic Value Beyond Rebates, and Current Rebate Concerns are Known and Manageable On August 7, 2018, CMS announced a new policy to expand th
Slide 10: Combination With Express Scripts Will Deliver Greater, Sustained Shareholder Value
Combination With Express Scripts Will Deliver Greater, Sustained Shareholder Value From October 2017 to deal announcement in March 2018, at the direction and with the oversight of Cigna’s Board, Cigna conducted significant due diligence. Points of focus included: The standalone valuation of Express
Slide 11: Cigna's current stock price represents a temporary dislocation
Cigna believes its current stock price represents a temporary dislocation and presents an outstanding opportunity for future, significant shareholder return Underperformance by acquirers is common in MCO M&A deals with pending DOJ reviews UnitedHealth Group – a peer with an integrated MCO and PBM bu
Slide 12: The Investment Community Clearly Supports the Combination
Driving Improved Affordability at Scale The Investment Community Clearly Supports the Combination Note: Permission to use quotes was not sought or obtained; Source: Wall Street Analyst Research Reports “We believe that the ongoing shift to value-based pricing models could also lessen the reliance on
Slide 13: Combined Company Will Grow Shareholder Value and Transform Healthcare
Combined Company Will Grow Shareholder Value and Transform Healthcare in an Increasingly Demanding Healthcare Environment A B C Cigna's Board and management team believe that its proposed merger with Express Scripts is in the best interest of shareholders and recommend that Cigna shareholders vote “
Express Scripts Holding — Merger or Acquisition (August 2018) on 6ix